SBI Okasan Asset Management Co.Ltd. acquired a new position in Synopsys, Inc. (NASDAQ:SNPS – Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 3,547 shares of the semiconductor company’s stock, valued at approximately $1,699,000.
Several other hedge funds also recently added to or reduced their stakes in SNPS. Brighton Jones LLC grew its position in Synopsys by 5.7% in the fourth quarter. Brighton Jones LLC now owns 921 shares of the semiconductor company’s stock worth $447,000 after acquiring an additional 50 shares during the period. Integrated Wealth Concepts LLC grew its position in Synopsys by 11.6% in the first quarter. Integrated Wealth Concepts LLC now owns 760 shares of the semiconductor company’s stock worth $326,000 after acquiring an additional 79 shares during the period. NewEdge Advisors LLC grew its position in Synopsys by 15.1% in the first quarter. NewEdge Advisors LLC now owns 3,010 shares of the semiconductor company’s stock worth $1,291,000 after acquiring an additional 395 shares during the period. WINTON GROUP Ltd grew its position in Synopsys by 9.2% in the second quarter. WINTON GROUP Ltd now owns 758 shares of the semiconductor company’s stock worth $389,000 after acquiring an additional 64 shares during the period. Finally, Treasurer of the State of North Carolina grew its position in Synopsys by 2.1% in the second quarter. Treasurer of the State of North Carolina now owns 72,095 shares of the semiconductor company’s stock worth $36,962,000 after acquiring an additional 1,505 shares during the period. 85.47% of the stock is currently owned by hedge funds and other institutional investors.
Synopsys News Roundup
Here are the key news stories impacting Synopsys this week:
- Positive Sentiment: Synopsys reported fiscal Q2 results above expectations, with revenue of $2.276 billion and non-GAAP EPS of $3.35, both topping estimates. The company also raised full-year revenue and EPS guidance, signaling continued demand for AI chip-design software and related tools. Synopsys Posts Financial Results for Second Quarter Fiscal Year 2026
- Positive Sentiment: Management said AI-related demand remains strong, and the company highlighted expanding benefits from the Ansys deal and operating-margin improvement, which could support longer-term growth. Synopsys raises annual forecast on demand for AI chip design software
- Positive Sentiment: Synopsys reached a cooperation agreement with Elliott Investment Management and added Elliott partner Jesse Cohn to its board, which may increase pressure for operational improvements and shareholder-friendly changes. Synopsys reaches settlement with Elliott, says Jesse Cohn to join board
- Neutral Sentiment: Several analysts responded positively by lifting price targets, but at least one firm still has an underperform/neutral view, showing that Wall Street is still split on the stock’s upside from current levels. Analyst target updates
- Neutral Sentiment: Commentary around the stock emphasizes valuation concerns after a strong run, suggesting some investors may be pausing to reassess how much of the AI growth story is already priced in. Is It Too Late To Consider Synopsys (SNPS) After Recent Valuation Concerns?
- Negative Sentiment: The shares fell despite the beat-and-raise report, indicating investors are worried about execution risk, integration complexity, and weakness in parts of the chip-IP business. Synopsys slides even as Q2 results, guidance top estimates; adds activist to board
Analyst Ratings Changes
Read Our Latest Research Report on Synopsys
Synopsys Stock Down 8.6%
Synopsys stock opened at $480.64 on Friday. Synopsys, Inc. has a 1-year low of $376.18 and a 1-year high of $651.73. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.36 and a quick ratio of 1.26. The stock has a market cap of $92.07 billion, a PE ratio of 111.26, a P/E/G ratio of 4.31 and a beta of 1.25. The stock’s fifty day moving average is $458.59 and its two-hundred day moving average is $454.30.
Synopsys (NASDAQ:SNPS – Get Free Report) last posted its earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 EPS for the quarter, topping analysts’ consensus estimates of $3.15 by $0.20. Synopsys had a return on equity of 5.91% and a net margin of 8.91%.The business had revenue of $2.28 billion for the quarter, compared to analysts’ expectations of $2.25 billion. During the same quarter in the previous year, the firm earned $3.67 earnings per share. The business’s revenue was up 41.9% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. On average, sell-side analysts expect that Synopsys, Inc. will post 10.28 EPS for the current fiscal year.
Synopsys Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Recommended Stories
- Five stocks we like better than Synopsys
- 3 Stocks Rallying on Micron’s Price Boost: Substance or Hype?
- Snowflake and the Snowballing Impact of its AI Flywheel
- AI’s Biggest Bottleneck Could Make These 2 Stocks Soar
- These 3 Beaten-Down Stocks Just Saw $25 Million in Insider Buying
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
